Some factors limiting transfer of biotechnology research for health care at Cinvestav: A Mexican scientific center

Nelly Medina-Molotla, Halla Thorsteinsdóttir, Eugenio Frixione and Walid Kuri-Harcuch

Technology in Society, 2017, vol. 48, issue C, 1-10

Abstract: We investigated a number of factors that influence the transfer and commercialization of biotechnology for health care at Cinvestav, a leading Mexican research institute and major contributor to biomedical sciences in the country. Mixed methods were used, where we sent a survey to all the principal investigators (PIs) doing research in health-oriented biotechnology at Cinvestav that we could identify and asked them about their transfer of technologies activities, and interviews were carried out with those PIs who are currently pursuing projects for commercialization. Our results show that, despite a strong publishing record on the international front, most of these scientists lack a business-oriented focus. Further business expertise does not appear to be readily available or helpful at the institutional technology transfer office. Weak collaboration strategies reflected in a low number of key partnerships, together with a lack of private financing, also limit the capacity to transfer and commercialize the technologies being generated. The local scientific tradition and conditions do not seem to be amenable to these kinds of efforts, nor does the government pursue a coherent strategy to promote technology transfer and commercialization in health biotechnology. Consequently, promising projects take too long to develop and usually go to a limited extent through the consecutive patenting and licensing steps, both indicators of commercial activity in academia. The end result is a lack of success in making the results of new scientific knowledge beneficial for public health, a problem experienced not only by Mexico but shared by a number of low-and-middle income countries. We discuss the need for an urgent change in concerted vision by research institutions in developing countries, so as to engage their robust scientific infrastructure with the social and health demands of their populations.

Keywords: R&D for health care biotechnology; Technology transfer; Patenting; Commercialization; Developing countries (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0160791X1630080X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:teinso:v:48:y:2017:i:c:p:1-10

DOI: 10.1016/j.techsoc.2016.10.004

Access Statistics for this article

Technology in Society is currently edited by Charla Griffy-Brown

More articles in Technology in Society from Elsevier
Bibliographic data for series maintained by Catherine Liu ().